149
Participants
Start Date
August 9, 2017
Primary Completion Date
July 8, 2019
Study Completion Date
July 8, 2019
CTP-543
Administered as tablets.
CTP-543 matching placebo
Administered as tablets.
Icahn School of Medicine at Mt. Sinai, New York
Wake Forest University Health Sciences, Winston-Salem
Siperstein Dermatology Group, Boynton Beach
Cleveland Clinic, Cleveland
Minnesota Clinical Study Center, Fridley
Northwestern University, Chicago
Suzanne Bruce & Associates, PA, Houston
Contour Dermatology & Cosmetic Surgery Center, Rancho Mirage
University of California, Irvine, Irvine
Stanford University School of Medicine, Redwood City
Kaiser Permanente Northern California, San Francisco
Northwest Dermatology, Portland
Yale School of Medicine, New Haven
Lead Sponsor
Concert Pharmaceuticals
INDUSTRY